Optimisation of combined therapy and clinico-laboratory control of children with bronchial asthma, using formoterol
Searching for exact ways and scheme of treatment and supervising asthma patients on long-acting form of b 2-agonist (Formoterol) therapy is still very actual. We studied 31 children (from 7 to 11 years) with moderate non-controled bronchial asthma during 12 weeks. As a basic therapy...
Main Authors: | L V Puschko, O V Alekseeva, T V Brilkova, T I Nazarova, T B Oboladze, E R Samitova |
---|---|
Format: | Article |
Language: | English |
Published: |
Peoples’ Friendship University of Russia (RUDN University)
2013-12-01
|
Series: | RUDN Journal of Medicine |
Subjects: | |
Online Access: | http://journals.rudn.ru/medicine/article/view/3205 |
Similar Items
-
Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01) -
ANALYSIS OF THE LEVEL OF TRANSFORMING GROWTH FACTOR β1 IN CHILDREN WITH BRONCHIAL ASTHMA
by: Наталья Леонидовна Потапова, et al.
Published: (2019-11-01) -
Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
by: A. V. Еmelyanov
Published: (2013-12-01) -
Modern approaches to the treatment of asthma in children
by: E. A. Vishneva, et al.
Published: (2014-12-01) -
Rational therapy of asthma in children with inhaled corticosteroids
by: N. A. Geppe, et al.
Published: (2016-12-01)